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Abstract
Background: Patients reaching end-stage renal disease must make a difficult decision regarding renal replacement
therapy (RRT) options. Because the choice between dialysis modalities should include patient preferences, it is
critical that patients are engaged in the dialysis modality decision. As part of the Empowering Patients on
Choices for RRT (EPOCH-RRT) study, we assessed dialysis patients’ perceptions of their dialysis modality decision-making
process and the impact of their chosen modality on their lives.
Methods: A 39-question survey was developed in collaboration with a multi-stakeholder advisory panel to assess
perceptions of patients on either peritoneal dialysis (PD) or in-center hemodialysis (HD). The survey was disseminated
to participants in the large US cohorts of the Dialysis Outcomes and Practice Patterns Study (DOPPS) and the Peritoneal
DOPPS (PDOPPS). Survey responses were compared between PD and in-center HD patients using descriptive statistics,
adjusted logistic generalized estimating equation models, and linear mixed regression models.
Results: Six hundred fourteen PD and 1346 in-center HD participants responded. Compared with in-center HD
participants, PD participants more frequently reported that they were engaged in the decision-making process, were
provided enough information, understood differences between dialysis modalities, and felt satisfied with their modality
choice. PD participants also reported more frequently than in-center HD participants that partners or spouses (79% vs.
70%), physician assistants (80% vs. 66%), and nursing staff (78% vs. 60%) had at least some involvement in the dialysis
modality decision. Over 35% of PD and in-center HD participants did not know another dialysis patient at the time of
their modality decision and over 60% did not know the disadvantages of their modality type. Participants using either
dialysis modality perceived a moderate to high impact of dialysis on their lives.
Conclusions: PD participants were more engaged in the modality decision process compared to in-center HD
participants. For both modalities, there is room for improvement in patient education and other support for
patients choosing a dialysis modality.
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Background
Over 120,000 patients reaching end-stage renal disease
(ESRD) every year in the United States (US) are faced with
a complex and difficult decision regarding renal replace-
ment therapy (RRT) modality options [1]. Although kidney
transplant results in the best clinical outcomes, 97% of
ESRD patients will require dialysis, most frequently periton-
eal dialysis (PD) or in-center hemodialysis (HD) [1]. Al-
though clinical contraindications restrict modality choice in
occasional cases, most patients are candidates for both PD
and HD [2]. Either dialysis modality may be a better fit for
a specific patient based on dialysis treatment characteristics
and their impact on daily life. Thus, the choice between
modalities should center on patient preferences, and it is
critical that patients are included and engaged in the dialy-
sis modality decision [3, 4]. This is supported by increasing
evidence that aligning treatment with patient preferences
may improve adherence to therapy, quality of life, and ul-
timately better medical outcomes [5–8].
Clinical practice guidelines support the role of patients
and their caregivers in the dialysis modality decision-mak-
ing process [5, 9–11]. Unfortunately, interviews with dialy-
sis patients show that many did not feel they were given
an active choice of modality [3, 12–14], despite wanting to
be involved in decision-making [3, 15]. To do so effect-
ively, patients and their caregivers must have a compre-
hensive understanding of the differences between dialysis
modalities and their impacts on daily life [16, 17]. How-
ever, previous studies have shown many patients felt un-
prepared and ill-informed about starting dialysis and
about different dialysis modalities [13, 18]. Dialysis educa-
tion can prepare patients for shared decision-making, and
may ultimately lead to better outcomes through more
active engagement in care [16, 19–22].
The Empowering Patients on Choices for Renal Re-
placement Therapy (EPOCH-RRT) study, supported by
the Patient-Centered Outcomes Research Institute
(PCORI), sought to develop a decision aid (http://choo
singdialysis.org) to help patients choose a dialysis modal-
ity. To determine factors that are most important to pa-
tients when considering dialysis, the EPOCH-RRT study
first conducted semi-structured interviews of patients with
chronic kidney disease (CKD) and patients undergoing PD
or in-center HD. Some of the factors participants identi-
fied were independence, flexibility in daily lives, concerns
about looks, and quality and quantity of life [14]. For this
part of the EPOCH-RRT study, we developed a survey
partly based on the information gained from interviews,
and we administered the survey to the large, national US
samples of participants in the Dialysis Outcomes and
Practice Patterns Study (DOPPS) and the Peritoneal DOPPS
(PDOPPS). Our aim was to assess participants’ percep-
tions of the dialysis modality decision-making process and
compare the impact of their chosen modality on their lives
with the goal to inform efforts to increase patient
engagement and ultimately contribute to improving
patient-centered outcomes.
Methods
Survey design
A 39-question survey (Additional file 1: Figure S1) to as-
sess participants’ experiences with the dialysis modality
decision and factors that participants had previously
identified as important (“patient-centered outcomes”)
was developed in collaboration with a multi-stakeholder
advisory panel and partly based on the analysis of quali-
tative data collected from 180 advanced CKD partici-
pants [14]. The advisory panel included dialysis patients,
caregivers (e.g., dialysis patients’ family members), and
patient advocates (e.g., social workers), who provided
perspectives on experiences with CKD and ESRD. The
advisory panel informed the development of the survey,
tested the survey for readability and comprehension, and
helped to review and finalize survey questions. Given the
panel members’ expertise with the target study popula-
tion and their personal experience as either patients or
caregivers, they were able to assess face validity, inter-
pretability, relevance, and comprehensiveness of ques-
tionnaire items. Questionnaires for PD vs. in-center HD
patients were identical except for the exchange of the
words “peritoneal dialysis” vs. “hemodialysis.” The survey
was designed for both paper and electronic (tablet) for-
mats, with substantial advisory panel input on layout
and design of the electronic survey. The survey was pro-
fessionally translated from English to Spanish and
reviewed by Spanish-speaking members of the institu-
tional review boards, then made available to study par-
ticipants in either English or Spanish.
Participants were asked whether they were told they
had a choice between PD and HD when starting dialysis
and to indicate if their involvement in this decision was
more, less, or just what they wanted. The survey pro-
ceeded with three sets of questions: (1) Participants
ranked the degree to which 10 groups of family mem-
bers, peers, and clinical staff were involved in their dialy-
sis modality decision, as suggested by the Decisional
Needs Assessment in Populations [23]. A Cronbach’s
alpha estimate of 0.89 indicated good reliability of these
questions to measure involvement of others in the deci-
sion process. (2) Participants rated their level of agree-
ment with nine statements focused on their recollection
of their experiences and satisfaction with their dialysis
modality decision. This set of questions was adapted for
the current study population from the COMRADE scale
[24] and Decision Regret Scale [25] and had a Cron-
bach’s alpha estimate of 0.86. Additionally, participants
were asked whether the information they had received
before starting dialysis was more, less, or just the
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amount that they had wanted and if they and their doc-
tor had agreed on the type of dialysis that was best for
them. (3) Participants ranked the degree to which dialy-
sis affected 16 factors compared with before starting dia-
lysis. These factors were chosen directly based on
previous research of the themes most often reported as
important to patients when choosing a dialysis modality
[14]. Cronbach’s alpha for this set of items was 0.93.
Participant enrollment
The DOPPS and PDOPPS are ongoing, international
prospective cohort studies of dialysis facility practices
and patient outcomes for adult in-center HD and PD
participants, respectively [26–28]. DOPPS and PDOPPS
participants are selected randomly from a national sam-
ple of dialysis facilities. All consented participants in the
US DOPPS and PDOPPS studies were eligible for the
EPOCH-RRT study. Study coordinators targeted as many
eligible participants as possible between February 2015
and August 2015 to participate in the EPOCH-RRT sur-
vey (Fig. 1). Some participants departed the dialysis facil-
ity before study coordinators could approach them with
the survey or were unable to participate due to other
reasons, such as cognitive, physical, language, or social
impediments. Others were approached for participa-
tion but unwilling to complete the EPOCH-RRT sur-
vey. Facilities were randomly assigned to receive the
survey on either paper or tablet platforms. Local in-
stitutional review boards (Ethical and Independent
Review Services #13016, Henry Ford Health Systems
#8144, University of Michigan HUM00073058) ap-
proved all study procedures.
Statistical analysis
For questions on the level of involvement of clinical
staff, families, and peers in the dialysis modality selec-
tion, we treated the responses as continuous outcomes.
Each degree of involvement (i.e., not at all, somewhat,
moderately, very much, or extremely) was assigned an
integer value from 1 to 5 such that the difference be-
tween two adjacent levels represented a 1-unit change.
For outcomes on experiences and satisfaction with the
dialysis modality decision, responses were dichotomized
into agreement (agree or strongly agree) vs. non-agree-
ment (strongly disagree, disagree, or neither agree or dis-
agree) for better model fit and ease of interpretation. For
outcomes on factors important to patients, responses
were also dichotomized into a large impact (very much
or extremely) vs. not large impact (not at all, somewhat,
or moderately). Participants who reported not applicable
were excluded from analyses of each corresponding
question. Missing responses for each question were
excluded.
For dichotomized outcomes (experiences and satisfac-
tion with the dialysis modality decision and factors im-
portant to patients), logistic generalized estimating
equation (GEE) regression models were used to compare
outcomes between PD and in-center HD participants.
An exchangeable working correlation matrix was used to
account for participant clustering within facility. For
continuous outcomes (involvement of clinical staff, fam-
ilies, and peers), linear mixed regression models were
used to compare dialysis modality, accounting for
clustering by including a random intercept for each facil-
ity. The primary predictor in all models was dialysis
Fig. 1 Recruitment of Study Participants
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modality, and all models were adjusted for age, sex,
black race, time on dialysis (vintage), and diabetes. Ad-
justed differences in probabilities or levels of each out-
come between PD and in-center HD, along with 95%
confidence intervals (CI), were estimated using model
parameter estimates. Predicted probabilities from logistic
regression models were estimated using means for con-
tinuous adjustment covariates and most frequent cat-
egories for categorical adjustment covariates.
We tested for an interaction between modality and
time on dialysis (< 1 year vs. ≥1 year and < 3 years vs.
≥3 years) in each model to assess whether dialysis vin-
tage modified differences in modality. Similarly, among
the subgroup of patients with such information, we
tested for an interaction between modality and having
prior RRT experience (i.e., in-center HD patients with
prior PD experience, PD patients with prior in-center
HD experience, and in-center HD or PD patients with
prior transplant). Because each interaction analysis in-
volved 38 different hypothesis tests, we applied the
Benjamini-Hochberg correction for multiple compari-
sons to control for false discovery rate [29]. We also
conducted two sets of sensitivity analyses: 1) we added
paper or tablet platform as an additional adjustment fac-
tor and tested for dialysis modality effect modification
by platform; 2) for dichotomized outcomes, we treated
them as continuous variables using linear models and
treated them as ordinal using proportional odds models.
All analyses were conducted using SAS, Version 9.4
(SAS Institute Inc., 2013, Cary, NC) or Stata, Version
13.1 (StataCorp, 2013, College Station, TX).
Results
Study participants
Out of 807 PD and 1683 in-center HD participants
approached for participation, 614 (76.1%) PD partici-
pants from 55 facilities and 1346 (80.0%) HD partici-
pants from 80 facilities responded to at least one
question in the survey (Fig. 1). Participant characteristics
are shown in Table 1. Compared to in-center HD partic-
ipants, PD participants were younger and were less likely
to be black, on average. PD participants also had shorter
dialysis vintage, with 46% having started dialysis less
than 2 years ago compared to 32% for in-center HD par-
ticipants. Age, sex, and race distributions of our study
sample were similar to those of the US dialysis popula-
tion, while participants in our study had shorter time on
dialysis, on average, than point prevalent dialysis patients
in the US in 2013 when these data were collected [1].
Survey completion
Out of 39 total questions, the median (interquartile
range) number of questions answered was 36 (33–38)
among PD participants and 35 (32–37) among in-center
HD participants. The amount of missingness for each
question ranged from 3 to 7%, with the exception of
question two, regarding the amount of patient involve-
ment in the dialysis modality decision compared to what
the participant wanted. This question was left un-
answered by 11% of PD participants and 36% of
in-center HD participants. In addition, there was a tech-
nical error with the question, “I know the disadvantages
of hemodialysis compared to peritoneal dialysis” on
some of the tablet questionnaires disseminated to
in-center HD participants. Therefore, responses to these
questions among tablet users (43%) were suppressed and
only responses from paper users were used for analyses.
Survey implementation platform
Among participants < 65 years old, response rates across
platform (i.e., paper vs. tablet) were similar among both
PD (63.2% paper vs. 66.1% tablet) and in-center HD
(68.4% paper and 71.9% tablet) participants. However,
participants older than 65 who were offered tablets had
lower response rates than those offered paper surveys
for PD (72.5% paper vs. 55.7% tablet) and in-center HD
(69.4% paper vs. 59.7% tablet).
Experience regarding dialysis modality choice
PD participants reported that they were more frequently
(93%) told that they had a choice between dialysis mo-
dalities than were in-center HD participants (66%). 10%
of PD participants and 20% of HD participants felt their
involvement in the type of dialysis they would start on
was either more than or less than they wanted, rather
than just what they wanted.
Involvement of clinical staff, family, and peers
Clinical staff members, especially nephrologists, were
most frequently involved in the dialysis modality decision
Table 1 Patient characteristics, by dialysis modality
Variable PD (n = 614)a HD (n = 1346)a
Patient age, mean (SD) years 59.9 (15.0) 63.0 (14.5)
Male 53.9% 57.4%
Race
White 70.2% 59.5%
Black 23.0% 35.8%
Other 6.8% 4.7%
Time on dialysis
0 to < 6 months 5.6% 6.2%
6 to < 12 months 11.4% 8.6%
12 to < 36 months 46.1% 31.1%
36+ months 30.6% 54.1%
Diabetes 41% 43.3%
aOne PD patient and 9 HD patients were missing demographic data
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overall (Fig. 2). Compared to in-center HD, fewer PD par-
ticipants reported involvement of primary care doctors
(60% vs. 70%). Greater differences were observed in the
two modalities when it came to involvement of other clin-
ical staff, with for example, 22% of PD participants and
40% of in-center HD participants reporting no involve-
ment at all of nursing staff in the dialysis decision. In ad-
justed models, the mean [95% CI] level of involvement of
physician assistants was 0.4 [0.2,0.6] higher for PD pa-
tients and of nursing staff was 0.7 [0.5,0.9] higher for PD
patients compared to in-center HD patients. Less than
65% of all participants reported knowing someone on dia-
lysis at the time of their modality decision; among them,
over 50% recalled no peer involvement. Also, more PD
participants than in-center HD participants reported at
least some involvement of partners/spouses (PD 79%, with
55% reporting very much or extremely; in-center HD 70%,
with 46% reporting very much or extremely; adjusted
mean [95% CI] difference of 0.3 [0.1,0.4] between PD and
HD). For both PD and in-center HD participants,
involvement of other family and friends was low to mod-
erate (32–60%).
Experiences and satisfaction with dialysis modality
decision
In-center HD participants felt less informed and less
confident than PD participants at the time of the dialysis
modality decision and were less satisfied with their mo-
dality choice (Fig. 3). PD participants more often felt the
information they were given was enough and easy to
understand, with adjusted differences [95% CI] between
PD and HD in the probability of agreement of 0.10
[0.07,0.13] and 0.08 [0.05,0.12], respectively. PD
participants more frequently agreed that dialysis choices
were explained (0.13 [0.09,0.16]), they understood the
advantages (0.22 [0.17,0.26]) and disadvantages (0.15
[0.09,0.22]) of their dialysis modality type, and they were
happy with their type of dialysis (0.14 [0.10,0.18]). Al-
most all PD participants felt their dialysis choices had
been explained in a way that was easily understandable,
Fig. 2 Involvement of family and peers in the dialysis modality decision. Patients who reported not applicable (range: 3% for nephrologist to 35%
for peer and 47% for adult child/children) were excluded from the relevant question. *Adjusted differences in the degree of involvement of
family members and peers between PD and in-center HD patients. Estimates from linear mixed regression models adjusted for age, sex, black
race, time on dialysis, and diabetes, and accounting for facility clustering
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whereas close to 20% of in-center HD participants did
not. Only 6% of PD participants regretted their choice of
dialysis modality, compared with 11% of in-center HD
participants (adjusted difference between PD and HD of
− 0.04 [− 0.07,-0.02]). While 26% of PD participants re-
ported that the information they had before starting dia-
lysis was either more (9%) or less (17%) than they
wanted, rather than just what they wanted, 36% of
in-center HD participants reported they had either more
or less information (11% and 25%, respectively) (p =
0.178). 95% of PD participants and 84% of in-center
HD participants reported that they and their doctor
agreed about the type of dialysis that was best for
them (p < 0.05).
Impact of dialysis on patients’ lives
A sizable number of participants on both in-center HD
and PD reported that dialysis had a large impact on all
factors assessed (range 17–46%, Fig. 4). In-center HD
participants were more affected than PD participants for
15 of 16 factors, but the differences were generally small.
PD participants felt their dialysis modality affected reli-
ance on themselves slightly more than HD participants,
with an adjusted difference in probability of agreement
of 0.05 [− 0.01,0.10] between PD and HD. The largest
differences between PD and in-center HD participants
were observed for the factors: doing what I want in my
free time (− 0.08 [− 0.13,−0.02]), doing activities I am in-
terested in (hobbies) (− 0.07 [− 0.12,−0.02]), drinking as
much water as I want (− 0.20 [− 0.25,−0.15]), and eating
what I like (− 0.14 [− 0.19,−0.08]).
Effect modification and sensitivity analyses
The interaction between modality and time on dialysis
(using 1 year or 3 years as a cut-point) was not statistically
significant in any model. The interaction between modal-
ity and prior RRT experience was also not statistically sig-
nificant in any model among the N = 140 patients with
prior RRT experience and N = 1159 patients without prior
RRT experience. Therefore, we did not find evidence that
time on dialysis or prior RRT experience modified the dif-
ferences in outcomes between PD and in-center HD. For
all outcomes, similar results were obtained after adjusting
additionally for platform (tablet vs. paper). In analyses
testing for interactions between modality (PD vs. in-center
HD) and questionnaire platform (tablet vs. paper), we
found little effect modification. In sensitivity analyses
treating dichotomized outcomes as continuous or ordinal,
Fig. 3 Patients’ self-reported experience and satisfaction with the dialysis modality decision. *Difference in probability and 95% confidence
interval (CI) of agreement with each statement comparing PD vs. in-center HD. Estimates from logistic GEE model adjusted for age, sex, black
race, time on dialysis, and diabetes, and accounting for facility clustering. Adjusted differences in predicted probabilities were calculated for a
white, non-diabetic male of average age and average vintage
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results were similar but model assumptions (i.e., normality
or proportional odds) were sometimes violated. Thus, we
concluded that logistic regressions were most appropriate
for these outcomes.
Discussion
By collaborating with an advisory panel and using analyses
from qualitative data collected from EPOCH-RRT
participant interviews, we developed a survey specifically
designed to focus on patient-centered outcomes. This
approach was consistent with PCORI goals for
multi-stakeholder engagement in research and was invalu-
able for informing the survey content and interpretation of
results. Our survey results showed that that participants
who were on PD were more informed and engaged in dia-
lysis modality decision-making compared with in-center
HD participants overall. This may be expected, given that
PD participants undergo intense training coordinated by
clinical staff and that this dialysis technique has an impact
on an entire household’s quality of life [30]. Therefore,
those who choose PD may already be more involved in
their own care and likely more receptive to education they
receive. Nonetheless, the low involvement of several
groups in the dialysis modality decision for both PD and
in-center HD participants demonstrates an opportunity to
increase family and peer engagement to promote shared
decision-making. Such engagement may result in a better
fit of the dialysis modality with each patient’s life, as well as
improved experience for their families and other caregivers
[31–33]. The large number of dialysis participants who did
not know someone else on dialysis highlights a potentially
useful but underutilized resource, for example. Beyond
having support of peers, peer mentoring programs have
been successful in different clinical conditions [34–37], and
anecdotal evidence indicates that existing peer support
programs in dialysis are highly valued by patients and their
caregivers [38, 39]. By improving awareness of and access
to peers and peer mentors, patients new to dialysis may
benefit from increased practical information about dialysis,
empathy and understanding, advice on coping strategies,
and a greater sense of empowerment and agency [39].
PD participants were much more likely than in-center
HD participants to report greater involvement in the
dialysis modality decision. Previous studies have found
that deficiencies in awareness of options are a barrier to
choosing PD and that educational interventions can in-
crease PD use [40–42]. Thus, health care providers may
offer PD as an option more often to patients with higher
health literacy or better self-care abilities. PD partici-
pants also more frequently indicated they were happy
with the modality they chose compared to in-center HD
participants. This result may reflect a more deliberate
Fig. 4 Effect of dialysis on patient-centered outcomes. Patients who reported not applicable (range: 1% to 9%) were excluded from the relevant
question. * Difference in probability and 95% confidence interval (CI) of a large impact of dialysis on each factor comparing PD vs. in-center HD.
Estimates from logistic GEE model adjusted for age, sex, black race, time on dialysis, and diabetes, and accounting for facility clustering. Adjusted
differences in predicted probabilities were calculated for a white, non-diabetic male of average age and average vintage
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and informed decision-making process among PD par-
ticipants and/or greater involvement in the dialysis mo-
dality decision. It may also reflect a more positive
perception of the dialysis experience specifically due to
self-reinforcement from feeling involved in the modality
decision process. Still, many PD participants did not
know the disadvantages of their modality and did not
feel they had written information that was easy to under-
stand. In both PD and HD groups, such a lack of infor-
mation and regret in the dialysis modality choice points
to opportunities to improve ESRD education for ad-
vanced CKD patients. Increased education could then
lead to increased understanding of dialysis modalities
and satisfaction with treatment, especially among those
who ultimately choose in-center HD [19, 20].
Several impactful factors were more frequently identi-
fied by in-center HD participants compared to PD partici-
pants. Some of these differences may be explained not
only by the differences in modality technique but also the
location and medical environment where dialysis is per-
formed. For example, clinical characteristics (e.g., lack of
residual urine output) of HD patients may require more
restrictive diets and fluid intake, while technical aspects of
in-center HD (e.g., intermittent dialysis in a facility set-
ting) often limit the time in-center HD patients have for
their own interests like travel [43]. Some in-center HD pa-
tients have also reported that dialyzing in a clinical setting
and being surrounded by other patients makes them feel
less healthy, although this opportunity to interact with
other patients in the in-center setting was not always per-
ceived as a negative aspect of in-center HD [3].
Overall, the proportion of participants who skipped
each question was low, supporting the fact that the sur-
vey questions were appropriate and easily interpretable
by most dialysis participants. This likely reflected the
high engagement of the advisory panel in the develop-
ment of the survey and reviews of survey questions.
There was a higher amount of missingness for one ques-
tion about the amount of the participant’s involvement
in the dialysis modality decision. The reasons for which
participants did not answer this question could include
not having preconceived desires about involvement in the
dialysis modality decision and/or unwillingness to admit
low involvement. Both suggest that more effort should be
made to give participants adequate choice and involve-
ment in their dialysis modality decision process and to
monitor patient involvement during that process [44].
There are a few limitations of our study worth noting.
First, survey questions asked the extent to which partici-
pants felt affected by dialysis, but did not ask whether par-
ticipants perceived the effects to be positive or negative.
Therefore, the direction of impact can only be speculated
based on what is known about the different modalities
until it can be elucidated by future research. Second,
patients’ perceptions of others’ involvement in PD training
may have inflated their perceptions of involvement in the
dialysis modality decision process. While it is plausible
that those who must later be involved in training also have
some involvement in the decision process, we cannot sep-
arate the two periods of involvement in our data. Third,
surveys were administered to both incident and prevalent
dialysis participants, so the time between dialysis initiation
and survey was variable and experiences reflect those of
survivors. Particularly for participants who had longer dia-
lysis vintage, recall bias may have affected survey re-
sponses related to the dialysis modality decision. However,
we have no reason to believe that the recall bias would be
different across PD and in-center HD participants, indicat-
ing that comparisons between modalities may still have lit-
tle bias. We also adjusted for vintage in models and found
no evidence of modality effect modification by vintage.
Fourth, we did not have information on whether partici-
pants in the study had contraindications to either dialysis
modality, which also may have affected survey responses.
For example, some in-center HD participants may not
have had PD available if starting dialysis acutely (informa-
tion not available in our data), which limited their expos-
ure to PD information. Still, these patients should be
empowered with information to decide whether to stay on
in-center HD or switch to PD when available. Finally,
comparisons between PD and in-center HD participants
may have been confounded by factors like frailty, comor-
bid diseases, educational background, social support, and
dialysis modality history. Although these variables were
not available for analysis, we did control for the most
common comorbidity of diabetes and age which is likely
to be correlated with frailty.
Conclusions
Our study has several strengths and important implica-
tions for ESRD patients and their families as well as for
health care providers. By comparing the experiences of
PD and in-center HD patients, we identified important
differences between these modalities. We found several
aspects of the dialysis modality decision that require im-
provement for both PD and in-center HD patients, includ-
ing patient education, access to peers, and other support.
Increased efforts are needed to encourage a holistic ap-
proach to care that involves multiple stakeholders and
provides resources such as decision aids for patients facing
the choice between dialysis modalities. It is our hope that
a focus on education and multi-stakeholder engagement
in the dialysis modality decision will empower patients,
their caregivers, and health care professionals to collabora-
tively choose a dialysis modality that best fits the
individual patient, with the goals of ultimately improving
satisfaction and health outcomes.
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Additional file
Additional file 1: Figure S1. Survey for PD Patients. HD patient survey
was identical, except with the exchange of the words “peritoneal dialysis”
and “hemodialysis.” (DOCX 447 kb)
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